From managing supply chain challenges to addressing the tight labor market, consumer products businesses face a variety of issues this year. … READ MORE >
Canada
Retailers capitalize on opportunities while restaurants look for consistency: Spring 2022 outlook
Retailers are looking to capitalize on changing consumer behaviors while restaurants continue to seek sure footing in 2022. … READ MORE >
Price increases are necessary but could prove costly for food and beverage companies: Spring 2022 outlook
Growing food and beverage businesses will maintain or improve market share while passing along costs to consumers. … READ MORE >
Can apparel sales growth continue? – Spring 2022 outlook
What’s in store for apparel and other consumer goods companies? From inventory levels to consumers’ increased mobility, there’s much to consider. … READ MORE >
How DeFi is reshaping capital markets, part 3: Spring 2022 outlook
Looking toward the rest of 2022, capital markets organizations need to become familiar with what tokens can enable—namely, bridging the gap between traditional and decentralized finance. … READ MORE >
3 priorities for insurers in the future of work: Spring 2022 outlook
A confluence of pressures is forcing many insurance companies to reinvent their traditional operating models. … READ MORE >
Automating compliance management can help firms offset rising costs: Spring 2022 outlook
Developments in technology-based solutions and tools offer many options for financial services companies to streamline their regulatory compliance and risk management programs while offsetting rising costs. … READ MORE >
Clinical trials and life sciences services: Spring 2022 outlook
From COVID-19 clinical trial starts to virtual trials, what’s impacting businesses in the life sciences services sector in 2022? … READ MORE >
Biopharma business outlook: Spring 2022
From approvals to investing, what’s on the horizon for middle market biopharma companies in 2022? … READ MORE >
The need for regulatory framework modernization: Spring 2022 medtech outlook
The number of novel medical devices brought to market continues to grow; keeping up with reviews will remain an ongoing challenge for the FDA. … READ MORE >